The “Guangdong Provincial Academician Workstation for Innovative Chiral Drug R&D" and the “Preparatory Platform for Chiral Drug Research and Evaluation Key Technologies” is a joint initiative established by Lewwin and Professor Xinzi Chen, Academician of the Chinese Academy of Sciences and Founding Academician of the Hong Kong Academy of Sciences. With notable achievements in the field of chiral drug evaluation, Lewwin Pharm currently has multiple chiral drugs under development. In recent years, it has supported enterprises in obtaining multiple clinical approval batches for chiral drugs and has filed several invention patents for chiral drug biological sample testing technologies. This collaboration brings together the strengths of both parties to create a comprehensive, internationally compliant platform for chiral drug research and evaluation.

The platform currently has one Class 1 innovative deuterated chiral compound under development, two modified compounds, and multiple drugs in the screening phase. Preliminary evaluations indicate that these compounds demonstrate superior safety and efficacy compared to non-deuterated chiral drugs.